Point-of-care anti-BCMA CAR T-cell therapy induces encouraging response rates in relapsed/ refractory multiple myeloma patients mostly with high-risk disease features Meeting Abstract


Authors: Shkury, E.; Fried, S.; Itzhaki, O.; Shem-Tov, N.; Danylesko, I.; Yerushalmi, R.; Shouval, R.; Nevo, L.; Shapira-Frommer, R.; Nagler, A.; Shimoni, A.; Avigdor, A.; Magen, H.
Abstract Title: Point-of-care anti-BCMA CAR T-cell therapy induces encouraging response rates in relapsed/ refractory multiple myeloma patients mostly with high-risk disease features
Meeting Title: 20th Annual Meeting and Exposition of the International Myeloma Society
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 23
Issue: Suppl. 2
Meeting Dates: 2023 Sep 27-30
Meeting Location: Athens, Greece
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2023-09-01
Start Page: S61
Language: English
ACCESSION: WOS:001079705400100
PROVIDER: wos
DOI: 10.1016/S2152-2650(23)01666-X
Notes: Meeting Abstract: P-048 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Roni Shouval
    149 Shouval